Frost & Sullivan Technology Innovation Award report

Press releases

2015, March 19: Leids biotechbedrijf BBB Therapeutics gered

2015, March 16: Doorstart voor biotechbedrijf BBB Therapeutics

2015, Jan 26: BBB Therapeutics filed for bankruptcy; Mr. M. Udink of Udink & De Jong ( appointed as administrator.

2014, Oct 20: BBB Therapeutics Appoints Jan van Heek as Chairman of the Supervisory Board

2014, Sep 30: to-BBB Completes Management Team and Announces Company Name Change to BBB Therapeutics

2014, Sep 12: to-BBB Announces Positive Data from Phase 1 Clinical Study

2014, Sep 9: Anders Harfstrand joins to-BBB as CEO

2014, Jun 30: to-BBB Announces Successful EUR 10 Million Financing

2014, January 13: Jan van Heek Nominated to Supervisory Board of BBB Therapeutics

2014, January 10: BBB Therapeutics Publishes Nonclinical Data on Lead Product 2B3-101

Show archive

Media coverage

2014, May 8: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies - Foundation Fighting Blindness

2014, April 16: Omroep MAX: BBB Therapeutics in het TV programma 'Geef om je Hersenen' van de Hersenstichting

2014, February 5: FD: Leidse farmaceut laat zich niet afschrikken door turbulent beursavontuur Prosensa (Dutch)

2014, January 20: Management Team: BBB Therapeutics: In biotech leef je altijd met grote onzekerheden (Dutch)

2014, January 9: Telegraaf: Oud-topman van Crucell naar beurskandidaat BBB Therapeutics (Dutch)

2013, December 16: HollandBIO: 25 years of Biotech in the Netherlands (Dutch)

2013, December 12: Telegraaf: Biotech in China-deal (Dutch)

2013, August 19: Telegraaf: Bestrijder hersenziekten droomt van beurssucces (Dutch)

2013, June 1: Antea Newsletter: De hersenkrakers (Dutch)

2013, May 9: LaboratoryNews: Overcoming the barrier to ALS

Show archive